BetterLife Pharma Inc. filed its 20-F on May 31, 2023 for the period ending Jan 31, 2023. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0888 USD | -1.83% |
|
+1.49% | +85.00% |
Jun. 14 | BetterLife Pharma Raises $530,000 in Private Placement | MT |
May. 29 | BetterLife Pharma Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+85.00% | 10.4M | |
+17.48% | 124B | |
+18.55% | 112B | |
+3.93% | 22.94B | |
-10.68% | 17.02B | |
-16.54% | 16.88B | |
-39.94% | 16.87B | |
+2.74% | 13.63B | |
+25.79% | 11.61B | |
+104.00% | 10.31B |
- Stock Market
- Equities
- BETRF Stock
- News BetterLife Pharma Inc.
- BetterLife Pharma Inc. Auditor Raises 'Going Concern' Doubt